Could 3D Sperm Imaging Improve IVF Selection in the Future?

A Clearer Look at Sperm Selection

Selecting a sperm cell for fertility treatment can involve more uncertainty than many patients realize. Embryologists can evaluate movement and outward appearance under a microscope, but a sperm cell is nearly transparent. Important structures inside it are difficult to see without stains that would make the cell unsuitable for fertilization.

Researchers at Tel Aviv University are studying a possible way around that limitation. Their imaging approach uses optical measurements to build detailed maps of sperm-cell structure without relying on a permanent chemical label for the final analysis. An artificial intelligence model then helps distinguish internal regions that are difficult to assess with standard brightfield microscopy.

The technology could eventually give embryologists more information when evaluating sperm for in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). For now, it remains an early imaging study. It has not been shown to select sperm that produce healthier embryos or to improve pregnancy or live-birth rates.

Why Sperm Selection Can Be Challenging

A standard semen analysis evaluates characteristics such as sperm concentration, movement, and morphology. These measurements provide valuable information about male fertility, but they do not reveal every feature that may matter during fertilization.

Sperm selection becomes especially direct during ICSI. In conventional IVF, many sperm are placed with an egg and fertilization occurs in the laboratory dish. During ICSI, an embryologist selects one sperm and injects it into an egg. That makes the assessment of an individual cell an important laboratory decision, although treatment success still depends on the egg, embryo development, laboratory conditions, and many other clinical factors.

Traditional microscopy mainly shows external shape and movement. Internal structures can be made more visible with fluorescent or chemical stains, but those techniques can damage or alter cells. A sperm selected for fertilization must remain viable, so a useful clinical method needs to gather more information without compromising the cell.

For a broader explanation of the two fertilization methods, see the difference between IVF and ICSI.

How the New Imaging Method Works

According to The Jerusalem Post’s July 2026 report on Tel Aviv University’s 3D sperm-imaging technology, the method combines optical tomography with interferometric imaging to generate high-resolution maps of sperm cells. It measures how light travels through different parts of a cell, creating a refractive-index map that can reveal internal variations not visible through routine clinical microscopy.

The researchers focused on structures including:

• The nucleus, which contains the sperm’s genetic material
• The acrosome, a cap-like structure containing enzymes involved in penetrating the egg
• The midpiece, which contains mitochondria that help power movement
• Regions associated with the centrioles, which have roles after fertilization and during early embryo development

The underlying study, published in Biomedical Optics Express as a label-free refractive-index map of human sperm cells, analyzed optical-path data from 42 human sperm cells. Researchers imaged cells in two surrounding media with different refractive indices, allowing them to separate information about cell thickness from information about the cell’s optical properties.

Fluorescence microscopy was used during the research to identify and validate the locations of internal structures. The eventual classification, however, was based on features extracted from the label-free optical images. That distinction matters: the study used staining as a research reference, while the proposed clinical value is the ability to analyze a usable sperm cell without staining it.

What the Artificial Intelligence Actually Identified

The team trained a machine-learning model using spatial, morphological, and textural features from the optical images. The model was designed to identify regions within the sperm head, particularly the nucleus and acrosome.

The Jerusalem Post reported that the model reached 89 percent sensitivity and 94 percent specificity when identifying internal structures. Those figures describe how well the model classified cellular regions in the study. They do not mean it predicted fertilization, pregnancy, miscarriage, embryo health, or live birth with those percentages.

This is an important difference whenever AI performance is discussed in fertility care. A model can perform well at an imaging task without yet proving that its use improves the outcomes patients care about most. Clinical studies would need to compare this method with current sperm-selection practices and follow results through fertilization, embryo development, pregnancy, and live birth.

Our article on what current evidence says about AI and IVF success explains why prediction accuracy and better patient outcomes are related questions, but not the same question.

Does Seeing More Mean Selecting a Healthier Sperm?

Potentially useful information is not the same as a complete measure of sperm health. A clearer view of the nucleus, acrosome, and other structures may help embryologists identify visible abnormalities more objectively. It may also reduce some of the subjectivity involved in choosing between sperm cells that look similar under a standard microscope.

However, an image cannot currently confirm that a sperm will fertilize an egg, support normal embryo development, or result in a healthy birth. A sperm cell can appear structurally typical and still have concerns that the imaging system was not designed or validated to detect. Conversely, morphology alone does not determine whether treatment will succeed.

That is why it is more accurate to describe this technology as a potential decision-support tool. It could add information to an embryologist’s assessment rather than replacing professional judgment or guaranteeing that the selected sperm is biologically superior.

What About Sperm DNA Fragmentation?

Sperm DNA fragmentation refers to breaks or damage within sperm DNA. It is different from the count, movement, and outward shape measured in a routine semen analysis. In selected clinical situations, a fertility specialist may discuss DNA-fragmentation testing alongside other parts of a male fertility evaluation.

The Tel Aviv team is investigating whether refractive-index imaging might eventually detect patterns associated with DNA fragmentation. The current published work did not establish that capability. It mapped and classified internal structures, not DNA damage.

If future studies show that the method can assess DNA integrity accurately without harming the sperm, it could have diagnostic or treatment-planning value. That would require validation against established laboratory tests, research in larger and more diverse samples, and evidence that using the information changes meaningful clinical outcomes.

Patients who are beginning this part of an evaluation can review how male fertility testing and assessment work for context on semen analysis and additional testing.

What Would Need to Happen Before Clinical Use?

Before this technology could become part of routine IVF or ICSI, researchers would need to answer several practical questions:

• Can live, moving sperm be imaged quickly enough during a clinical procedure?
• Does the process preserve sperm function and viability?
• Does the system work consistently across different samples and fertility diagnoses?
• Can independent laboratories reproduce the imaging and AI results?
• Does selecting sperm with this information improve fertilization or embryo development?
• Most importantly, does it improve pregnancy or live-birth outcomes without adding meaningful risk?

The research results have reportedly been licensed for commercial development, but licensing does not establish clinical effectiveness or regulatory approval. Patients should not assume that a technology is proven simply because it is being developed for fertility clinics.

A More Informed Future for Male Fertility Care

Male factors are involved in a substantial share of infertility cases, yet sperm assessment still leaves important biological questions unanswered. Tools that reveal more about individual cells without making them unusable could eventually support more objective laboratory decisions and more personalized care.

At Her Serenity, we believe emerging fertility technologies deserve both attention and perspective. Patients should be able to understand what a new tool measures, what its early results mean, and what evidence is still missing.

This 3D imaging approach is an inventive step toward seeing sperm cells in greater detail. Whether that clearer view translates into better IVF or ICSI outcomes will depend on careful clinical validation. Until then, it is best understood as promising research that may one day complement the experience of skilled embryologists and fertility specialists.